| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/18/2006 | EP1615649A1 Parenteral formulation of mycophenolic acid, a salt or prodrug thereof |
| 01/18/2006 | EP1615646A1 Pharmaceutical formulations containing methylnaltrexone |
| 01/18/2006 | EP1286663B1 Encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 01/18/2006 | EP1214064A4 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 01/18/2006 | EP1210085B1 Pharmaceutical solutions of levosimendan |
| 01/18/2006 | EP1200320B9 Valve with a two-component seal |
| 01/18/2006 | EP1200115B9 Multi-dose erythropoietin formulations |
| 01/18/2006 | EP1028708A4 Topical compositions for prostaglandin e 1? delivery |
| 01/18/2006 | EP0841901A4 Polymeric drug formulations |
| 01/18/2006 | EP0819004A4 Pharmaceutical composition containing proton pump inhibitors |
| 01/18/2006 | CN1723220A A pharmaceutical composition comprising an immunoglobulin FC region as a carrier |
| 01/18/2006 | CN1723219A Protein complex using immunoglobulin fragment andmethod for the preparation thereof |
| 01/18/2006 | CN1723206A High specificity anticancer pharmacological drug system, drug synthesis, and drug development process |
| 01/18/2006 | CN1723041A Stable immunogenic product comprising antigenic heterocomplexes |
| 01/18/2006 | CN1723021A Stable solid medicinal composition for oral administration. |
| 01/18/2006 | CN1720997A Method for preparing antineoplastic nanometer heat sensitive target medicine carrier |
| 01/18/2006 | CN1720996A Antineoplastic nanometer heat sensitive target medicine carrier used combined with chemical therapy and heat therapy |
| 01/18/2006 | CN1720995A The treatment of respiratory diseases |
| 01/18/2006 | CN1720969A Chinese proprietary medicine |
| 01/18/2006 | CN1720922A Preparation of anti-infection CpG oligonucleotide DNA preparation and its application technology |
| 01/18/2006 | CN1720919A Mesalazine controlled release oral pharmaceutical compositions |
| 01/18/2006 | CN1720916A Rapidly decomposing administrable form for releasing active ingredient in oral cavity or bodily cavity |
| 01/18/2006 | CN1720912A Pharmaceutical compositions |
| 01/18/2006 | CN1720904A Hemodilution facilitated by monitoring oxygenation status |
| 01/18/2006 | CN1237179C Targeted artificial gene delivery |
| 01/18/2006 | CN1236831C Compositions for protein delivery via the pulmonary route |
| 01/18/2006 | CN1236813C Self-emulsifying compositions for drugs poorly soluble in water |
| 01/18/2006 | CN1236777C Stabilized brivudine topical formulations containing metal oxide pigments |
| 01/18/2006 | CN1236775C Compositions and methods for reducing ocular hypertension |
| 01/18/2006 | CN1236774C Highly concentrated stable meloxicam solutions |
| 01/18/2006 | CN1236773C Preparation for analgesia and anesthesia or treating drug dependence |
| 01/18/2006 | CN1236764C Method for preparing a composition |
| 01/18/2006 | CN1236759C New pharmaceutical preparation for pain management |
| 01/18/2006 | CN1236758C Slow-releasing injection contg. hydrocastor oil/medicine (for treatment) solid dispersion microparticle |
| 01/18/2006 | CN1236754C Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier |
| 01/18/2006 | CN1236692C Microcapsules |
| 01/17/2006 | US6987166 Anti-C5a antibodies |
| 01/17/2006 | US6987133 Topical spray for burn treatment and anti-infection |
| 01/17/2006 | US6987129 Treating vaginismus, dyspareunia, interstitial cystitis, vulvodynia, vulvar vestibulitis, nonspecific urethritis, female sexual arousal orgasmic disorders or increasing vaginal lubrication, etc. |
| 01/17/2006 | US6987108 Pharmaceutical formulations of antineoplastic agents and processes of making and using the same |
| 01/17/2006 | US6987096 genetic engineering of a cyanovirin; gene therapy; exogenous gene expression; use alone or in combination with antiviral agents such as AZT; AIDS therapy |
| 01/17/2006 | US6987094 Optimized formulation of tobramycin for aerosolization |
| 01/17/2006 | US6987023 DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use |
| 01/17/2006 | US6987012 Biological compositions and methods for treatment of colorectal cancer |
| 01/17/2006 | US6987006 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases |
| 01/17/2006 | US6986908 Delta-aminolevulinic acid for prevention and treatment of infection by pathogenic microorganisms and parasite |
| 01/17/2006 | US6986905 Pharmaceutical compositions for treating and saving and the method for the preparation thereof |
| 01/17/2006 | US6986900 biocompatible implants for delivery of pharmaceutically active agents to the posterior segment of the eye; having a scleral surface, an orbital surface, an injection port on the orbital surface, and a fluid conducting passageway |
| 01/17/2006 | US6986896 Administering formulation comprising urea and dermatologically acceptable excipients for therapy of onychomycosis infection of nail area |
| 01/17/2006 | US6986346 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage |
| 01/17/2006 | CA2338792C Rapidly disintegrable solid preparation |
| 01/17/2006 | CA2286753C Solid pharmaceutical preparation |
| 01/17/2006 | CA2129079C Orally administrable cholesterol lowering agent |
| 01/16/2006 | CA2512059A1 Transdermal drug delivery formulations with optimal amounts of vasodilators therein |
| 01/12/2006 | WO2006005058A2 Polymer-factor ix moiety conjugates |
| 01/12/2006 | WO2006004577A2 Lubricant for the ocular surface |
| 01/12/2006 | WO2006004390A2 Preparation and use of a bivalent vaccine against morphine-heroin addiction |
| 01/12/2006 | WO2006003518A2 6-phosphorylcholine-n-acetyl-d-galactosamine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications against bacterial infection of the respiratory tract |
| 01/12/2006 | WO2006003352A1 Living radical polymerization initiator comprising a functional group capable of reacting with polyeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom |
| 01/12/2006 | WO2006003299A1 Hydroalcoholic depigmentation gel comprising mequinol and adapalene |
| 01/12/2006 | WO2006003014A2 Hydrogel polymeric conjugates of a prodrug |
| 01/12/2006 | WO2006002895A2 Conjugates of antibody and duoarmycin derivatives as antitumor agents |
| 01/12/2006 | WO2006002887A1 Aqueous drink solution of indibulin (d-24851) and an organic acid |
| 01/12/2006 | WO2006002814A1 Ultrasound-assisted synthesis of cyclodextrin-based nanosponges |
| 01/12/2006 | WO2005103230A3 Soy peptone as a nitrogen source in preparing meningococcal conjugates |
| 01/12/2006 | WO2005046449A3 Soluble tcr molecules and methods of use |
| 01/12/2006 | WO2005037949A3 Aerosol formulations of butalbital, lorazepam, ipratropium, baclofen, morphine and scopolamine |
| 01/12/2006 | WO2005027836A3 Immunogen |
| 01/12/2006 | WO2005025551A3 Pharmaceutical products comprising bisphosphonates |
| 01/12/2006 | WO2005011575A3 Stabilization and ionic triggering of nitric oxide release |
| 01/12/2006 | WO2004080401A3 Oral insulin therapies and protocol |
| 01/12/2006 | WO2004045497A3 Cd26-based therapies for cancers and immune disease |
| 01/12/2006 | WO2003084470A3 Compositions and methods for targeted biological delivery of molecular carriers |
| 01/12/2006 | WO2002020715A3 Peptide conjugated anti-cancer prodrugs |
| 01/12/2006 | US20060009622 inflammatory bowel disease, rheumatoid arthritis, acromegaly, tuberculosis, tumor of the lung, breast, brain, eye, prostate or colon, a tumor of neuroendocrine origin, an angiogenesis disease that causes inappropriate proliferation of blood vessels, retinal macular degeneration or diabetic neuropathy |
| 01/12/2006 | US20060009590 Hydrolytically stable maleimide-terminated polymers |
| 01/12/2006 | US20060009513 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 01/12/2006 | US20060009503 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 01/12/2006 | US20060009474 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans |
| 01/12/2006 | US20060009462 Prodrugs of CC-1065 analogs |
| 01/12/2006 | US20060009447 Pharmaceutical compositions comprising midazolam in a high concentration |
| 01/12/2006 | US20060009420 Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate |
| 01/12/2006 | US20060009411 Targeting compounds to a cell nucleus |
| 01/12/2006 | US20060009387 Apo-2 ligand/trail formulations |
| 01/12/2006 | US20060009380 Isolated deoxyribonucleic acid fragment that codes for the calcium binding proteins; treating skin disorders, like dry skin, hyperkeratosis, parakeratosis, psoriasis, ichthyosis, and neoplasia; cosmetics |
| 01/12/2006 | US20060009375 Site-specific drug delivery |
| 01/12/2006 | US20060008791 Incorporating saccharide having the structure of cyclo{6)- alpha -D-glucopyranosyl-(1 3)- alpha -D-glucopyransyl-(1 6)- alpha -D-glucopyranosyl-(1 3)- alpha -D-glucopyranosyl-(1}, into, with, or in a food product, cosmetic, pharmaceutical, or industrial chemical containing water |
| 01/12/2006 | US20060008532 Complexes of protein crystals and ionic polymers |
| 01/12/2006 | US20060008509 synergistic efficacy; polar lipid supplement, a soluble fiber, and a nutricine such as threonine |
| 01/12/2006 | US20060008508 Dry powder; administering htrough feeding tube |
| 01/12/2006 | US20060008507 System for generating a bioactive dosage form |
| 01/12/2006 | US20060008483 Dispersions of lipids for use as therapeutic and cosmetic agents and intracellular delivery vehicles |
| 01/12/2006 | US20060008481 Topically applying bactericide gentian violet (methylrosaniline) and a suppository base; soothing and healing effect |
| 01/12/2006 | US20060008478 Immunoadjuvant |
| 01/12/2006 | US20060008475 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to Gb3 expressing tumors |
| 01/12/2006 | US20060008464 Histone conjugates and uses thereof |
| 01/12/2006 | US20060008461 Delivering into phagocytic cells; targeting specific organelles; inhibiting, attenuating, arresting, combating and overcoming microbial infection of phagocytic mammalian cells in vivo and in vitro |
| 01/12/2006 | US20060008447 Comprises purified mannitol which reduces formation of interferon-beta adducts |
| 01/12/2006 | US20060008443 Ophthalmic compositions for lubricating eyes and methods for making and using same |
| 01/12/2006 | US20060008420 Nasal spray formulation and method |